Besremi (ropeginterferon alfa-2b-njft subcutaneous injection – PharmaEssentia) — Cigna

Initial criteria

• Patient has a diagnosis of polycythemia vera
• Patient age ≥ 18 years
• Medication is prescribed by or in consultation with an oncologist

Approval duration

1 year